These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19190236)

  • 1. Nonpeptidergic allosteric antagonists differentially bind to the CXCR2 chemokine receptor.
    de Kruijf P; van Heteren J; Lim HD; Conti PG; van der Lee MM; Bosch L; Ho KK; Auld D; Ohlmeyer M; Smit MJ; Wijkmans JC; Zaman GJ; Smit MJ; Leurs R
    J Pharmacol Exp Ther; 2009 May; 329(2):783-90. PubMed ID: 19190236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel allosteric binding site in the CXCR2 chemokine receptor.
    de Kruijf P; Lim HD; Roumen L; Renjaän VA; Zhao J; Webb ML; Auld DS; Wijkmans JC; Zaman GJ; Smit MJ; de Graaf C; Leurs R
    Mol Pharmacol; 2011 Dec; 80(6):1108-18. PubMed ID: 21948388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common intracellular allosteric binding site for antagonists of the CXCR2 receptor.
    Salchow K; Bond ME; Evans SC; Press NJ; Charlton SJ; Hunt PA; Bradley ME
    Br J Pharmacol; 2010 Apr; 159(7):1429-39. PubMed ID: 20233217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
    Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor.
    Widdowson KL; Elliott JD; Veber DF; Nie H; Rutledge MC; McCleland BW; Xiang JN; Jurewicz AJ; Hertzberg RP; Foley JJ; Griswold DE; Martin L; Lee JM; White JR; Sarau HM
    J Med Chem; 2004 Mar; 47(6):1319-21. PubMed ID: 14998320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The collagen-breakdown product N-acetyl-Proline-Glycine-Proline (N-alpha-PGP) does not interact directly with human CXCR1 and CXCR2.
    de Kruijf P; Lim HD; Overbeek SA; Zaman GJ; Kraneveld AD; Folkerts G; Leurs R; Smit MJ
    Eur J Pharmacol; 2010 Sep; 643(1):29-33. PubMed ID: 20599927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor.
    Bradley ME; Bond ME; Manini J; Brown Z; Charlton SJ
    Br J Pharmacol; 2009 Sep; 158(1):328-38. PubMed ID: 19422399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a putative intracellular allosteric antagonist binding-site in the CXC chemokine receptors 1 and 2.
    Nicholls DJ; Tomkinson NP; Wiley KE; Brammall A; Bowers L; Grahames C; Gaw A; Meghani P; Shelton P; Wright TJ; Mallinder PR
    Mol Pharmacol; 2008 Nov; 74(5):1193-202. PubMed ID: 18676678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2.
    Moriconi A; Cesta MC; Cervellera MN; Aramini A; Coniglio S; Colagioia S; Beccari AR; Bizzarri C; Cavicchia MR; Locati M; Galliera E; Di Benedetto P; Vigilante P; Bertini R; Allegretti M
    J Med Chem; 2007 Aug; 50(17):3984-4002. PubMed ID: 17665889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlapping, nonidentical binding sites of different classes of nonpeptide antagonists for the human gonadotropin-releasing hormone receptor.
    Betz SF; Reinhart GJ; Lio FM; Chen C; Struthers RS
    J Med Chem; 2006 Jan; 49(2):637-47. PubMed ID: 16420049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent and orally bioavailable N,N'-diarylurea antagonists for the CXCR2 chemokine receptor.
    Jin Q; Nie H; McCleland BW; Widdowson KL; Palovich MR; Elliott JD; Goodman RM; Burman M; Sarau HM; Ward KW; Nord M; Orr BM; Gorycki PD; Busch-Petersen J
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4375-8. PubMed ID: 15357956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat.
    Garau A; Bertini R; Mosca M; Bizzarri C; Anacardio R; Triulzi S; Allegretti M; Ghezzi P; Villa P
    Eur Cytokine Netw; 2006 Mar; 17(1):35-41. PubMed ID: 16613761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of new disubstituted phenyl-containing 3,4-diamino-3-cyclobutene-1,2-diones as CXCR2 receptor antagonists.
    Lai G; Merritt JR; He Z; Feng D; Chao J; Czarniecki MF; Rokosz LL; Stauffer TM; Rindgen D; Taveras AG
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1864-8. PubMed ID: 18304809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR2 antagonists for the treatment of pulmonary disease.
    Chapman RW; Phillips JE; Hipkin RW; Curran AK; Lundell D; Fine JS
    Pharmacol Ther; 2009 Jan; 121(1):55-68. PubMed ID: 19026683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G; Jones C; Wreggett KA
    Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists.
    Baxter A; Cooper A; Kinchin E; Moakes K; Unitt J; Wallace A
    Bioorg Med Chem Lett; 2006 Feb; 16(4):960-3. PubMed ID: 16297626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonists.
    Yu Y; Dwyer MP; Chao J; Aki C; Chao J; Purakkattle B; Rindgen D; Bond R; Mayer-Ezel R; Jakway J; Qiu H; Hipkin RW; Fossetta J; Gonsiorek W; Bian H; Fan X; Terminelli C; Fine J; Lundell D; Merritt JR; He Z; Lai G; Wu M; Taveras A
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1318-22. PubMed ID: 18242983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, ADMET Properties, and Biological Evaluation of Benzothiazole Compounds Targeting Chemokine Receptor 2 (CXCR2).
    Mehanna WE; Lu T; Debnath B; Lasheen DS; Serya RAT; Abouzid KA; Neamati N
    ChemMedChem; 2017 Jul; 12(13):1045-1054. PubMed ID: 28544630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative structure-activity relationships for small non-peptide antagonists of CXCR2: indirect 3D approach using the frontal polygon method.
    Khlebnikov AI; Schepetkin IA; Quinn MT
    Bioorg Med Chem; 2006 Jan; 14(2):352-65. PubMed ID: 16182534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CXCR2 (hCXCR2) takes over functionalities of its murine homolog in hCXCR2 knockin mice.
    Mihara K; Smit MJ; Krajnc-Franken M; Gossen J; Rooseboom M; Dokter W
    Eur J Immunol; 2005 Sep; 35(9):2573-82. PubMed ID: 16094689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.